Market capitalization | $2.94b |
Enterprise Value | $24.93b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 27.31 |
EV/Sales (TTM) EV/Sales | 2.71 |
P/S ratio (TTM) P/S ratio | 0.32 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 10.20% |
Revenue (TTM) Revenue | $9.20b |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
7 Analysts have issued a Bausch Health Companies Inc. forecast:
7 Analysts have issued a Bausch Health Companies Inc. forecast:
Dec '23 |
+/-
%
|
||
Net Profit | -592 -592 |
163%
163%
|
|
Depreciation and Amortization | 1,264 1,264 |
9%
9%
|
|
Stock Compensation | 132 132 |
5%
5%
|
|
Operating Cash Flow | 996 996 |
225%
225%
|
|
Investments | 272 272 |
1%
1%
|
|
Dividend Paid | - - |
-
|
|
Free Cash Flow | 781 781 |
177%
177%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Manufactures and markets pharmaceutical products
Head office | Canada |
CEO | Thomas Appio |
Employees | 20,270 |
Founded | 1994 |
Website | www.bauschhealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.